The Texas Heart Institute’s Drs Salim Virani and Matthew Segar look back at the history of SGLT2 inhibitors, which have roots in a fascinating FDA initiative focused on cardiovascular outcomes in diabetes medications. They explore the serendipitous beginnings of these groundbreaking medicines and their significant impact on cardiovascular health.
Watch this episode on Texas Heart TV
Allan Zhang, Ramsey Kalil, Alexander Marzec, Stephanie A. Coulter, Salim Virani, Kershaw V. Patel, Matthew W. Segar; Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer. Tex Heart Inst J 1 January 2024; 51 (1): e238375. doi: https://doi.org/10.14503/THIJ-23-8375
Watch On Demand Videos on Texas Heart TV
Visit Our Website: texasheart.org
Popular Podcasts
24/7 News: The Latest
The latest news in 4 minutes updated every hour, every day.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com